Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (7119)	3/2/1999 8:27:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

Aetna May Face Court Case After Refusing Viagra Cover, FT Says Washington, March 2 (Bloomberg) -- Aetna Inc., the biggest U.S. health insurer, may face federal legal action from men denied insurance coverage for Viagra, the anti-impotence drug made by Pfizer Inc., after a U.S. court rejected a defense motion that would have dismissed the suit, the Financial Times reported without citing sources. The suit was filed against Aetna Life Insurance Company and Aetna US Healthcare of California on behalf of men suffering from sexual dysfunction; the unnamed lead plantiff is impotent following prostrate cancer surgery, the newspaper said. Aetna and various other insurance companies have said Viagra is a ''lifestyle'' drug which is not medically necessary, the newspaper said. Viagra became the world's fastest-growing prescription drug after its introduction last year in the U.S., Europe and elsewhere. The drug generated sales of $788 million between its debut the first week of April and Dec. 31.